Royal Pharmaceutical Society of Great Britain, http://www.mollercentre.co.uk
Monday 23 – Wednesday 25 November 2009
MONDAY 23 NOVEMBER 09.30 Registration 10.15 Introduction (Kendal Pitt, GlaxoSmithKline)
10.45 Granules and tablets: A review of the reasons for granulation and tabletting, the classes of excipients and principles of operation of tabletting machines (Graham Buckton, University of London) 11.30 Material properties of importance for tabletting(I) (Graham Buckton, University of London) 12.15 Material properties of importance for tabletting (II) (Graham Buckton, University of London) 12.45 Lunch 13.45 A brief introduction to modified release (Graham Buckton, University of London) 14.15 Dissolution testing (Graham Buckton, University of London) 14.45 Key aspects of tablet formulation and characterisation (Michael Wilkins, GlaxoSmithKline) 15.45 Tea 16.00 Problem based learning 1: Active Pharmaceutical Ingredient (API) (Kendal Pitt, GlaxoSmithKline) Problem based learning 2: Formulation development
(Michael Wilkins, GlaxoSmithKline) 16.45 Problem based learning (continued)
17.30 Close 18.30 Informal reception 19.30 Dinner
TUESDAY 24 NOVEMBER 08.15 Tabletting Machines and in-process control (Brian Helsdon, Manesty) 09.15 Punch design (Terry Lewis, Casburt Limited) 10.15 Coffee 10.30 Compaction simulation (Kendal Pitt, GlaxoSmithKline) 11.30 An introduction to pharmaceutical coating technology (Marshall Whiteman, Quindell Consulting) 12.30 Lunch 13.30 Coating-advances in techniques of formulation (Marshall Whiteman, Quindell Consulting) 14.30 Production workshop - two groups with (Terry Lewis, Casburt Limited and Tesh Patel, Astellas) 15.30 Tea 15.45 Production workshop - second session 16.45 Close of days programme 17.10 Social programme 19.45 Dinner
WEDNESDAY 25 NOVEMBER
08.30 Process Analytical Technolgy (PAT) applied to tabletting (Ken Leiper, Benson Associates) 09.30 Roller Compaction (Kendal Pitt, GlaxoSmithKline) 10.15 Coffee 10.30 Granulation equipment and end point control automation (Ashley Clarke, Merck, Sharp & Dohme) 11.15 Continuous processing concepts (Michael Wilkins, GlaxoSmithKline) 12.00 Lunch 13.00 Scale-up of tablet manufacturing processes and transfer from R&D to production (Ashley Clark, Merck, Sharp & Dohme) 13.45 Compaction characterisation and process understanding (Kendal Pitt) 14.45 Concluding discussion 15.00 Close
|